Letter to Senator Dianne Feinstein on Signing an Executive Order on
Access to HIV/AIDS Pharmaceuticals and Medical Technologies
� May 10, 2000
� Dear Senator Feinstein:
� I am pleased to inform you that today I will sign an Executive
Order that is intended to help make HIV/AIDS-related drugs and
medical technologies more accessible and of fordable in beneficiary
sub-Saharan African countries. The Executive Order, which is based
in large part on your work in connection with the proposed Trade and
Development Act of 2000, formalizes U.S. government policy in this
area. It also directs other steps to be taken to address the spread
of HIV and AIDS in Africa, one of the worst health crises the world
faces.
� As you know, the worldwide HIV/AIDS epidemic has taken a terrible
toll in terms of human suffering. Nowhere has the suf fering been as
great as in Africa, where over 5,500 people per day are dying from
AIDS. Approximately 34 million people in sub-Saharan Africa have
been infected and, of those infected, approximately 11.5 million
have died. These deaths represent more than 80 percent of the total
HIV/AIDS-related deaths worldwide.
� To help those countries most affected by HIV/AIDS fight this
terrible disease, the Executive Order directs the U.S. Government to
refrain from seeking, through negotiation or otherwise, the
revocation or revision of any law or policy imposed by a beneficiary
sub-Saharan government that promotes access to HIV/AIDS
pharmaceuticals and medical technologies. This order will give
subSaharan governments the flexibility to bring life saving drugs
and medical technologies to affected populations. At the same time,
the order ensures that fundamental intellectual property rights of
U.S. businesses and inventors are protected by requiring sub-Saharan
governments to provide adequate and effective intellectual property
protection consistent with World Trade Organization rules. In this
way, the order strikes a proper balance between the need to enable
sub-Saharan governments to increase access to HIV/ AIDS
pharmaceuticals and medical technologies and the need to ensure that
intellectual property is protected.
� I know that you preferred that this policy be included in the
Conference Report on the Trade and Development Act of 2000, as did
I. However, through this Executive Order, the policy this
Administration has pursued with your support will be implemented by
the U.S. Government. The Executive Order will encourage beneficiary
sub-Saharan African countries to build a better infrastructure to
fight diseases like HIV/AIDS as they build better lives for their
people. At the same time, the Trade and Development Act of 2000 will
strengthen African economies, enhance African democracy, and expand
U.S.African trade. Together, these steps will enable the United
States to forge closer ties with our African allies, broaden export
opportunities for our workers and businesses, and promote our values
around the world.
� Thank you for your leadership on this critically important issue.
� Sincerely,
� William J. Clinton
� NOTE: An original was not available for verification of the content
of this letter.